Hengrui Pharma (01276) has issued an announcement revealing that, as of August 31, 2026, the company has not yet started implementing its share repurchase plan.

According to the disclosure, as of the date of this announcement, there is no discrepancy between the actual progress of the buyback and the terms outlined in the repurchase scheme.